Viral Clearance Market
Viral Clearance Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Viral Clearance Market Size and Growth
The Viral Clearance market is experiencing significant growth, driven by increasing demand in biopharmaceuticals and stringent regulations. As of 2023, the market is valued at approximately $1.5 billion, with projections indicating a compound annual growth rate (CAGR) of over 10% through 2030, highlighting the critical need for effective viral filtration and inactivation technologies.
Request Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ Wuxi Biologics (Cayman)
◍ Merck
◍ Charles River Laboratories International
◍ Kedrion
◍ Vironova Biosafety
◍ Texcell
◍ Clean Cells
The viral clearance market features key players like Wuxi Biologics, Merck, and others, focusing on enhancing safety in biopharmaceuticals. These companies employ advanced technologies and services, driving market growth. Notable sales revenues include Merck at $59.6 billion, Charles River at $2.5 billion, and Kedrion at $1.1 billion. Request Sample Report
Market Segmentation
By Application
◍ Recombinant Proteins
◍ Blood and Blood Products
◍ Vaccines
◍ Other Applications
By Product
◍ Viral Removal
◍ Chromatography
◍ Nanofiltration
◍ Precipitation
◍ Viral Inactivation
◍ Low pH ◍ Solvent Detergent Method
◍ Pasteurization
◍ Other Viral Inactivation Methods
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
